In the molecular structure of Lrp4, the first propeller domain interacts with agrin; in the third -propeller domain, its edge part mediates the MuSK signaling and its central cavity mediates the Wnt signaling

In the molecular structure of Lrp4, the first propeller domain interacts with agrin; in the third -propeller domain, its edge part mediates the MuSK signaling and its central cavity mediates the Wnt signaling. extracellular matrix proteins (participating in the synaptic stabilization) and presynaptic receptors (including muscarinic and adenosine receptors), we review the functional structures of the synapse by making reference to immunological pathogenecities in postsynaptic disease, myasthenia gravis. The synapse-related proteins including cortactin, coronin-6, caveolin-3, doublecortin, R-spondin 2, amyloid precursor family proteins, glia cell-derived neurotrophic factor and neurexins are also discussed in terms of their possible contribution to efficient synaptic transmission at the neuromuscular junction. strong class=”kwd-title” Keywords: neuromuscular junction, agrin, Wnts, muscle-specific tyrosine kinase, low-density lipoprotein receptor-related protein 4, laminins, myasthenia gravis, nicotinic acetylcholine receptor, muscarinic acetylcholine receptor, adenosine receptor 1. Introduction The neuromuscular junction is a cholinergic synapse where agrin, Wnts, low-density lipoprotein receptor related-protein 4 (Lrp4), PF-04554878 (Defactinib) muscle-specific tyrosine kinase (MuSK) and extracellular matrix proteins are required for the complex differentiation and precise alignment of the pre- and postsynaptic structures. The signalings via agrin/Lrp4-MuSK (Ig1/2 domains, participating in the innervated stage of muscle) and Wnt/Lrp4-MuSK (cysteine-rich domain, participating in the non-innervated stage of muscle and axonal guidance) contribute to nicotinic acetylcholine receptor (nAChR) clustering, trans-synaptic communication and synaptic stability [1,2]. In myasthenia gravis (MG) mainly caused by the nAChR antibodies, a proportion of the patients harbor antibodies recognizing MuSK and Lrp4 which are responsible for pre- and postsynaptic impairments and contributive, at least in part, to a defect in ACh-release upregulation to compensate for postsynaptic dysfunction [3,4,5,6,7,8,9,10]. The following points will be emphasized below: (1) heterogeneity of postsynaptic MuSK and Lrp4 antibodies in their binding to functional domains which are responsible for pre- and postsynaptic functions; (2) the key molecular mediators such as Wnts, MuSK and Lrp4 act bidirectionally to form pre- and postsynaptic architectures; (3) the compensatory upregulation of ACh quantal release depending on the modulation via muscarinic and adenosine receoptors in the nerve terminal; and (4) Laminin-network and synaptic collagens (linking to MuSK) participating in synaptic stabilization. 2. Postsynaptic Organizations, Centered on MuSK, Lrp4 and Synapse-Related Proteins MuSK is uniquely positioned as a key protein in the neuromuscular junction (NMJ). The ectodomain of muscle-derived MuSK consists of four immunoglobulin-like domains (Ig domains). The cysteine-rich domain (CRD, Ig4 domain) interacts with Wnts and thereby operates on synaptic function via the Wnts non-canonical signaling pathway [1,2,11,12,13,14,15,16,17,18]. Wnts belong to the Wingless-type mouse mammary PF-04554878 (Defactinib) tumor virus (MMTV) integration site family of glycoproteins which are released from motor neurons or derived from muscles; 19 different Wnt molecules exist in mice and humans [2]. The PF-04554878 (Defactinib) interaction of MuSK CRD with Wnts leads to nAChR clustering at the non-innervated stage of muscle through dishevelled scaffolding protein (Dvl) for the prepatterning of nAChR clusters (nAChR microcluster formation at the central part of muscle membrane where incoming axons are guided) and converges on the neural agrin-mediated signaling (Figure 1). The first and second immunoglobulin-like domains (Ig1/2 domains) conduct the neural agrin signal to form full-sized nAChR clusters in the innervated stage of muscle [1,2,19,20,21,22] (Figure 1). The nAChR clusters are anchored in the muscle membrane by rapsyn which is immobilized by MuSK-linking heat-shock proteins [23,24] (Figure 1). The negative regulation by the muscle-derived Wnt (such MMP3 as Wnt3a)-canonical pathway via -catenin/glycogen synthese kinase-3 reduces the expression of rapsyn, resulting in the reduction of agrin-mediated AChR clustering; this regulation maintains balance PF-04554878 (Defactinib) with the positive regulatory neuron-derived Wnt (such as Wnt3) and thereby helps to sculp the mature synaptic architecture; Wnt3 activates Rac1 in a more efficient usage than agrin which preferentially increases Rho activity [15,17]. The muscle-derived Lrp4 contributes to nAChR cluster formation by acting as the receptor for both Wnts and agrin at both non-innervated and innervated muscle membranes; Lrp4 can activate MuSK even without agrin [25,26,27,28,29] (Figure 1). In the molecular structure of PF-04554878 (Defactinib) Lrp4, the first propeller domain interacts with agrin [20]; in the third propeller domain, its edge part mediates the MuSK signaling and its central part mediates the Wnt signaling [30]. Adenomatous polyposis coli (APC) contributes to nAChR clustering and supports a cross-talk between agrin- and Wnt-mediated signaling pathways by coordinating the function of actin and the microtubule cytoskeleton during synapse formation [31]..